- Info
- Insider Trading
- Financials
- Holders: INDV, INDV
Deferred Tax Assets, Net of Valuation Allowance of Indivior Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Dec 2025
- Taxonomy & unit
- us-gaap: USD
- Description
- Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.
- Summary
-
Indivior Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Net of Valuation Allowance in USD history and change rate from 31 Dec 2023 to 31 Dec 2025.
- Indivior Pharmaceuticals, Inc. Deferred Tax Assets, Net of Valuation Allowance for the quarter ending 31 Dec 2025 was $326,000,000, a 15% increase year-over-year.
- Source SEC data
- View on sec.gov
Deferred Tax Assets, Net of Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Net of Valuation Allowance, YoY Quarterly Change (%)
Indivior Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Net of Valuation Allowance (USD)
| Period | Value | YoY Chg | Change % | Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | $326,000,000 | +$43,000,000 | +15% | 31 Dec 2025 | 10-K | 26 Feb 2026 | 2025 | FY |
| Q4 2024 | $283,000,000 | -$10,000,000 | -3.4% | 31 Dec 2024 | 10-K | 26 Feb 2026 | 2025 | FY |
| Q4 2023 | $293,000,000 | 31 Dec 2023 | 10-K | 03 Mar 2025 | 2024 | FY |
* An asterisk sign (*) next to the value indicates that the value is likely invalid.